NEW YORK (GenomeWeb) – Swedish diagnostic developer Immunovia said today that it has established a US subsidiary in Boston. The facility will house a CLIA reference lab and commercialization operations for the firm, which is preparing to launch its first test — a liquid biopsy assay for pancreatic cancer called Immray PanCan-d — in the first half of 2018.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
05
Sponsored by
Linguamatics

This webinar will discuss how Sanofi used literature mining to annotate the association of human leukocyte antigen (HLA) alleles with diseases and drug hypersensitivity as part of a multiple sclerosis (MS) biomarker discovery project.

Jun
14
Sponsored by
Sophia Genetics

This webinar will discuss an effort underway at the University of North Carolina Medical Center's to overcome limitations in the hematological genomic testing workflow with artificial intelligence (AI) from Sophia Genetics.